12.07.2015 Views

Annual Report 10-11 - Elder Pharmaceuticals Ltd.

Annual Report 10-11 - Elder Pharmaceuticals Ltd.

Annual Report 10-11 - Elder Pharmaceuticals Ltd.

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Balance Sheetas at 31st March 20<strong>11</strong>SCHEDULENo.As at31st March 20<strong>11</strong>(` in Lacs)As at31st March 20<strong>10</strong>SOURCES OF FUNDS :SHAREHOLDERS' FUNDS :Share Capital 1 2,056.67 Reserves and Surplus 2 59,055.13 LOAN FUNDS :Secured Loans 3 57,153.65 Unsecured Loans 17,715.14 DEFERRED TAX LIABILITY : 1,435.84 1,087.68 348.16 TOTAL 136,328.75 APPLICATION OF FUNDS :FIXED ASSETS : 57,094.09 9,516.86 47,577.23 9,302.74 INVESTMENTS 1,087.47 CURRENT ASSETS, LOANS AND ADVANCES :Inventories 18,489.77 22,665.74 25,167.42 Other Current Assets <strong>10</strong> 776.85 Loans And Advances <strong>11</strong> 26,968.05 94,067.83 Less : CURRENT LIABILITIES AND PROVISIONS: 12 12,140.48 Provisions 13 3,566.04 15,706.52 NET CURRENT ASSETS 78,361.31 TOTAL 136,328.75 20For S S KHANDELWAL & CO. Jagdish Saxena Alok Saxena Yusuf Karim KhanChartered Accountants (S S KHANDELWAL) Suresh V. Pai S. P. Date Company Secretary54

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!